HealthMedicine
Clinics test a five-day course for a common winter virus
A trial is asking whether a shorter treatment works as well for low-risk patients, which could ease pressure on pharmacies.
A trial opening this month will test whether a five-day course of treatment works as well as the standard ten days for low-risk patients with a common winter virus.
If the shorter course is effective, clinics say it could reduce waiting times and ease pressure on pharmacies during the busiest weeks of the year.
Why shorter might work
The longer course was chosen decades ago, before newer tests made it easier to identify who is likely to recover quickly. Researchers stress that nobody should change their treatment without advice.
“We are not trying to use less medicine for its own sake. We are trying to use the right amount.”
Results are expected in the spring. The trial will also track whether symptoms return more often after the shorter course.
Priya Raman
Health and science reporter
Priya reports on medicine, research and public health, with a particular interest in how evidence moves from a trial into a clinic. She trained as a pharmacist before becoming a journalist.